Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00736749 · ClinicalTrials.gov registry record
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
A clinical trial of Leukemia and Solid Tumor, sponsored by Children's Oncology Group.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 20
- Study locations
NCT00736749: Recruiting study of Leukemia and Solid Tumor, sponsored by Children's Oncology Group.
NCT00736749 is a study of Leukemia and Solid Tumor that is actively recruiting participants, run by Children's Oncology Group. The registered enrollment target is 5,000 participants, above the 465-participant average among 233 other Leukemia trials with a reported enrollment target (975% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00736749, a study of Leukemia and Solid Tumor, is actively recruiting participants, sponsored by Children's Oncology Group.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Assessment of Therapy Complications
Study Locations (20)
California
- Kaiser Permanente Downey Medical Center - Downey
- City of Hope Comprehensive Cancer Center - Duarte
- Loma Linda University Medical Center - Loma Linda
- Miller Children's and Women's Hospital Long Beach - Long Beach
- Children's Hospital Los Angeles - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- Mattel Children's Hospital UCLA - Los Angeles
- Valley Children's Hospital - Madera
- Kaiser Permanente-Oakland - Oakland
- Children's Hospital of Orange County - Orange
- Lucile Packard Children's Hospital Stanford University - Palo Alto
- University of California Davis Comprehensive Cancer Center - Sacramento
- Rady Children's Hospital - San Diego - San Diego
Alabama
- Children's Hospital of Alabama - Birmingham
- University of Alabama at Birmingham Cancer Center - Birmingham
- USA Health Strada Patient Care Center - Mobile
Arizona
- Phoenix Childrens Hospital - Phoenix
- The University of Arizona Medical Center-University Campus - Tucson
Arkansas
- Arkansas Children's Hospital - Little Rock
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2008-07-17 |
What NCT00736749 shows while recruiting
NCT00736749 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 465-participant average among 233 other Leukemia trials with a reported enrollment target (975% higher).
The record links to 3 conditions, with Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT00736749 names 20 study sites across 4 states, led by California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00736749 about?
NCT00736749 is a clinical study titled "Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies". This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn m...
What is the current status of trial NCT00736749?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2008-07-17.
What conditions does trial NCT00736749 study?
This clinical trial studies the following conditions: Leukemia, Solid Tumor, Hematopoietic Cell Transplantation Recipient.
What interventions are being tested in trial NCT00736749?
The interventions under investigation include: Questionnaire Administration (OTHER), Assessment of Therapy Complications (PROCEDURE).
Who is sponsoring clinical trial NCT00736749?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00736749 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00736749's enrollment target sits among peer trials
5,000 3rd of 233 higher than 231 of 233 other Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
- NCT00991094 · 5,000 participants
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI